Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Jumde, Varsha R
Ünver, M Yagiz
Camacho, Carlos Jamie
Hirsch, Anna K H
MetadataShow full item record
AbstractPharmacophore searches that include anchors, fragments contributing above average to receptor binding, combined with one-step syntheses are a powerful approach for the fast discovery of novel bioactive molecules. Here, we are presenting a pipeline for the rapid and efficient discovery of aspartyl protease inhibitors. First, we hypothesized that hydrazine could be a multi-valent warhead to interact with the active site Asp carboxylic acids. We incorporated the hydrazine anchor in a multicomponent reaction and created a large virtual library of hydrazine derivatives synthetically accessible in one-step. Next, we performed anchor-based pharmacophore screening of the libraries and resynthesized top-ranked compounds. The inhibitory potency of the molecules was finally assessed by an enzyme activity assay and the binding mode confirmed by several soaked crystal structures supporting the validity of the hypothesis and approach. The herein reported pipeline of tools will be of general value for the rapid generation of receptor binders beyond Asp proteases.
CitationChemMedChem. 2020;15(8):680‐684. doi:10.1002/cmdc.202000024.
AffiliationHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
The following license files are associated with this item:
- Creative Commons
- AnchorQuery: Rapid online virtual screening for small-molecule protein-protein interaction inhibitors.
- Authors: Koes DR, Dömling A, Camacho CJ
- Issue date: 2018 Jan
- Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection.
- Authors: Pathak N, Lai ML, Chen WY, Hsieh BW, Yu GY, Yang JM
- Issue date: 2017 Dec 28
- Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
- Authors: Prabhu SV, Tiwari K, Suryanarayanan V, Dubey VK, Singh SK
- Issue date: 2017
- Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
- Authors: Islam MA, Pillay TS
- Issue date: 2015 Mar
- Virtual screening with AutoDock Vina and the common pharmacophore engine of a low diversity library of fragments and hits against the three allosteric sites of HIV integrase: participation in the SAMPL4 protein-ligand binding challenge.
- Authors: Perryman AL, Santiago DN, Forli S, Martins DS, Olson AJ
- Issue date: 2014 Apr